Dongling Dai
Impact in
-
- Cancer-related molecular mechanisms research
-
- Metabolism and Genetic Disorders
Papers in
- Epidemiology 16
- Liver Disease Diagnosis and Treatment 9
- Multiple and Secondary Primary Cancers 2
- Co-authors
- Shaoming Zhou (7 shared papers)Feiqiu Wen (5 shared papers)Liang Liu (2 shared papers)Dongmei Zou (2 shared papers)Huanhuan Wang (1 shared paper)Sixi Liu (4 shared papers)Qinghua Yang (5 shared papers)Guosheng Liu (2 shared papers)
- Journals
- World Journal of Gastroenterology (4 papers)Transplant International (2 papers)BMC Gastroenterology (2 papers)Cell Death Discovery (1 paper)Journal of Inherited Metabolic Disease (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Dongling Dai
35 papers receiving 246 citations
Peers
Comparison fields: 5 of 54
- Cancer Research 48
- Clinical Biochemistry 22
- Hepatology 17
- Epidemiology 64
- Surgery 63
Countries citing papers authored by Dongling Dai
This map shows the geographic impact of Dongling Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongling Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongling Dai more than expected).
Fields of papers citing papers by Dongling Dai
This network shows the impact of papers produced by Dongling Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongling Dai. The network helps show where Dongling Dai may publish in the future.
Co-authors
The 25 scholars most cited alongside Dongling Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 54 | |
| 2 | 2022 | 31 | |
| 3 | 2019 | 22 | |
| 4 | 2017 | 17 | |
| 5 | 2024 | 16 | |
| 6 | [A case-control study on the risk factors of esophageal cancer in Linzhou]. | 2000 | 12 |
| 7 | 2018 | 11 | |
| 8 | 2017 | 9 | |
| 9 | 2020 | 9 | |
| 10 | 2021 | 9 | |
| 11 | Therapeutic effect of transcatheter arterial chemoembolization and percutaneous injection of acetic acids on primary liver cancer. | 2004 | 8 |
| 12 | 2016 | 7 | |
| 13 | 2023 | 6 | |
| 14 | 2016 | 5 | |
| 15 | 2019 | 4 | |
| 16 | 2024 | 3 | |
| 17 | 2025 | 3 | |
| 18 | [Quantitative analysis of E-cadherin expression and clinicopathologic evaluation in gastric cancer]. | 1997 | 3 |
| 19 | 2022 | 3 | |
| 20 | Effect of Ligustrazine on MDA,SOD and T-AOC in Erythrocyte Membrane in Patients with Hemoglobin H Disease | 2010 | 2 |
About Dongling Dai
Dongling Dai is a scholar working on Epidemiology, Molecular Biology, Oncology, Surgery and Physiology, having authored 41 papers that have together received 256 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (9 papers), Pediatric health and respiratory diseases (3 papers), Infant Nutrition and Health (2 papers), Adipose Tissue and Metabolism (2 papers), Multiple and Secondary Primary Cancers (2 papers), Cancer-related molecular mechanisms research (2 papers), Inflammatory Bowel Disease (2 papers) and Metabolism and Genetic Disorders (2 papers). The work is most often cited by research in Cancer Research (48 citations), Clinical Biochemistry (22 citations), Hepatology (17 citations), Epidemiology (64 citations) and Surgery (63 citations). Dongling Dai has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Shaoming Zhou, Feiqiu Wen, Liang Liu, Dongmei Zou, Huanhuan Wang, Sixi Liu, Qinghua Yang, Guosheng Liu, Jens Stahlschmidt and William J. Griffiths. Their work appears in journals such as World Journal of Gastroenterology, Transplant International, BMC Gastroenterology, Cell Death Discovery and Journal of Inherited Metabolic Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.